ABBV

AbbVie

Health Care

Biotechnology

North Chicago, Illinois

Balance Sheet 35 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$5.5B	$12.8B	$9.2B	$9.7B	$8.4B
Assets - AccountsReceivable	$10.9B	$11.2B	$11.3B	$10.0B	$8.8B
Assets - Inventories	$4.2B	$4.1B	$3.6B	$3.1B	$3.3B
Assets - TotalCurrentAssets	$25.6B	$33.0B	$28.5B	$27.9B	$24.2B
Assets - Property,PlantAndEquipment	$5.1B	$5.0B	$4.9B	$5.1B	$5.2B
Assets - Goodwill	$35.0B	$32.3B	$32.2B	$32.4B	$33.1B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$60.1B	$55.6B	$67.4B	$76.0B	$82.9B
Assets - MarketableSecuritiesNoncurrent	$169.0M	$159.0M	$129.0M	$149.0M	$102.0M
Assets - DeferredTaxAssets	$6.0B	$6.5B	$5.5B	$5.2B	$5.4B
Assets - OperatingLeaseAssets	$723.0M	$744.0M	$737.0M	$762.0M	$895.0M
Assets - FinanceLeaseAssets	$33.0M	$35.0M	$25.0M	$33.0M	$27.0M
Assets - OtherNoncurrentAssets	$9.1B	$8.5B	$5.6B	$4.9B	$4.9B
Assets - TotalNoncurrentAssets	$5.1B	$5.0B	$4.9B	$5.1B	$5.2B
Assets - TotalAssets	$135.2B	$134.7B	$138.8B	$146.5B	$150.6B
Liabilities - AccountsPayable	$2.9B	$3.7B	$2.9B	$2.9B	$2.3B
Liabilities - AccruedLiabilities	$6.7B	$6.4B	$5.8B	$5.3B	$6.2B
Liabilities - OperatingLeaseLiabilitiesCurrent	$178.0M	$166.0M	$166.0M	$178.0M	$175.0M
Liabilities - FinanceLeaseLiabilitiesCurrent	$17.0M	$15.0M	$17.0M	$9.0M	$8.0M
Liabilities - ContingentConsiderationLiabilityCurrent	$2.6B	$2.0B	$1.5B	$1.2B	—
Liabilities - TotalCurrentLiabilities	$38.7B	$37.8B	$29.5B	$35.2B	$28.7B
Liabilities - LongTermDebt	$66.8B	$59.2B	$63.1B	$76.0B	$84.9B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$697.0M	$735.0M	$754.0M	$713.0M	$832.0M
Liabilities - FinanceLeaseLiabilitiesNoncurrent	$23.0M	$27.0M	$17.0M	$25.0M	$21.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$2.6B	$2.0B	$2.2B	$3.0B	$3.6B
Liabilities - ContingentConsiderationLiabilityNoncurrent	$19.1B	$17.9B	$14.9B	$13.6B	$12.3B
Liabilities - OtherNoncurrentLiabilities	$30.1B	$32.3B	$30.7B	$28.7B	$27.6B
Equity - PreferredStock	$200.0M	$200.0M	$200.0M	$200.0M	$200.0M
Equity - CommonStock	$5.8B	$5.8B	$5.8B	$5.8B	$5.8B
Equity - RetainedEarnings(deficit)	$-7.9B	$-1.0B	$4.8B	$3.1B	$1.1B
Equity - TreasuryStock	$8.2B	$6.5B	$4.6B	$3.1B	$2.3B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-1.9B	$-2.3B	$-2.2B	$-2.9B	$-3.1B
Equity - NoncontrollingInterest	$39.0M	$37.0M	$33.0M	$28.0M	$21.0M
Equity - TotalStockholdersEquity	$3.3B	$10.4B	$17.3B	$15.4B	$13.1B
Equity - TotalLiabilitiesAndStockholdersEquity	$135.2B	$134.7B	$138.8B	$146.5B	$150.6B

Income Statement 22 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetRevenues/ProductSales	$56.3B	$54.3B	$58.1B	$56.2B	$45.8B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold/CostOfSales	$16.9B	$20.4B	$17.4B	$17.4B	$15.4B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$12.8B	$7.7B	$6.5B	$6.9B	$6.4B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative	$14.8B	$12.9B	$15.3B	$12.3B	$11.3B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$7.6B	$7.9B	$7.7B	$7.7B	$5.8B
IncomeStatement - CostsAndExpenses - ImpairmentCharges(operating)	$4.5B	$4.2B	$770.0M	$50.0M	$0
IncomeStatement - OtherIncomeExpense - GrossProfit	$10.7B	$8.6B	$11.0B	$10.6B	$9.2B
IncomeStatement - OtherIncomeExpense - OperatingIncome(loss)	$9.1B	$12.8B	$18.1B	$17.9B	$11.4B
IncomeStatement - OtherIncomeExpense - InterestExpense	$2.8B	$2.2B	$2.2B	$2.4B	$2.5B
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-3.2B	$-4.7B	$-2.4B	$-2.5B	$-5.6B
IncomeStatement - OtherIncomeExpense - Income(loss)BeforeIncomeTaxes	$3.7B	$6.2B	$13.5B	$13.0B	$3.4B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$-570.0M	$1.4B	$1.6B	$1.4B	$-1.2B
IncomeStatement - IncomeTax - EffectiveTaxRate	$-0	$0	$0	$0	$-0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$4.3B	$4.9B	$11.8B	$11.5B	$4.6B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToNoncontrollingInterest	$8.0M	$10.0M	$9.0M	$7.0M	$6.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$4.3B	$4.9B	$11.8B	$11.5B	$4.6B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$2	$3	$7	$6	$3
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$2	$3	$7	$6	$3
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$1.8B	$1.8B	$1.8B	$1.8B	$1.7B
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$1.8B	$1.8B	$1.8B	$1.8B	$1.7B
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$4.7B	$4.8B	$12.5B	$11.8B	$5.1B

Cash Flow Statement 24 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$4.3B	$4.9B	$11.8B	$11.5B	$4.6B
CashFlow - OperatingActivities - DepreciationAndAmortization	$764.0M	$752.0M	$778.0M	$803.0M	$666.0M
CashFlow - OperatingActivities - ShareBasedCompensation	$911.0M	$747.0M	$671.0M	$692.0M	$753.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-1.4B	$-2.9B	$-1.9B	$-898.0M	$-2.3B
CashFlow - OperatingActivities - ImpairmentCharges(nonCash)	$4.5B	$4.2B	$770.0M	$50.0M	$0
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$-249.0M	$539.0M	$2.4B	$1.7B	$835.0M
CashFlow - OperatingActivities - NetCashFromOperatingActivities	$18.8B	$22.8B	$24.9B	$22.8B	$17.6B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e)	$974.0M	$777.0M	$695.0M	$787.0M	$798.0M
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$73.0M	$77.0M	$1.4B	$119.0M	$61.0M
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$17.5B	$0	$255.0M	$525.0M	$38.3B
CashFlow - InvestingActivities - OtherInvestingActivities	$-189.0M	$-13.0M	$-774.0M	$-366.0M	$-1.4B
CashFlow - InvestingActivities - NetCashFromInvestingActivities	$-20.8B	$-2.0B	$-623.0M	$-2.3B	$-37.6B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$17.0B	—	$2.0B	$1.0B	$3.0B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$1.7B	$2.0B	$1.5B	$934.0M	$978.0M
CashFlow - FinancingActivities - PaymentOfDividends	$11.0B	$10.5B	$10.0B	$9.3B	$7.7B
CashFlow - FinancingActivities - PaymentForContingentConsideration(financing)	$0	$752.0M	$1.1B	$698.0M	$321.0M
CashFlow - FinancingActivities - OtherFinancingActivities	$57.0M	$48.0M	$30.0M	$24.0M	$8.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities	$-5.2B	$-17.2B	$-24.8B	$-19.0B	$-11.5B
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-65.0M	$5.0M	$-62.0M	$-97.0M	$-5.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$-7.3B	$3.6B	$-545.0M	$1.3B	$-31.5B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$4.1B	$4.7B	$3.0B	$3.6B	$1.7B
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$2.8B	$2.5B	$2.5B	$2.7B	$2.6B
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$159.0M	$173.0M	$235.0M	$66.0M	$692.0M

AbbVie

Balance Sheet 35 Accounts • 5 Years

Income Statement 22 Accounts • 5 Years

Cash Flow Statement 24 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History